Sunshine Noah: Planned fundraising of no more than 240 million yuan for the construction of a nucleic acid platform and to supplement cash flow.

Sunshine Nou announced that the company plans to issue stocks to specific investors through a simplified procedure, raising funds of no more than 240 million yuan. After deducting issuance expenses, 190 million yuan will be used for the research and development of nucleic acid drug discovery and pilot experimental platform construction project, and 50 million yuan will be used to supplement working capital. Nucleic acid drugs have been included in the encouraged category, and the use of the funds raised is in line with national policies, which will help enhance the company's position and competitiveness in the field of nucleic acid drug development services.